Parametrica Management Ltd portfolio

Q2 2017 · Holdings as of · Filed ·
$106.01MFull value: $106,011,000 · USD · 30 Jun 2017
reported in Form 13F

What changed in Q2 2017?

Comparable share positions since Q1 2017.

View all holdings
New
174
Increased
35
Reduced
33
Exited
199

1 position with incomplete comparison or price data excluded.

Largest disclosed changes

  1. EMB New

    ISHARES TR

    +180.5KFull value: +180,504 · shares · 30 Jun 2017
    shares
    +$20.66MFull value: +$20,664,000 · USD · 30 Jun 2017 · Estimated from share changes and filing prices
    estimated

    Weight +19.49 percentage points

  2. FMC Exited

    F M C CORP

    -14.49KFull value: -14,490 · shares · 30 Jun 2017
    shares
    -$1.01MFull value: -$1,008,000 · USD · 30 Jun 2017 · Estimated from share changes and filing prices
    estimated

    Weight -1.06 percentage points

  3. PTLA New

    PORTOLA PHARMACEUTICALS INC

    +16.93KFull value: +16,930 · shares · 30 Jun 2017
    shares
    +$951KFull value: +$951,000 · USD · 30 Jun 2017 · Estimated from share changes and filing prices
    estimated

    Weight +0.9 percentage points

  4. VRTX Exited

    VERTEX PHARMACEUTICALS INC

    -8.62KFull value: -8,624 · shares · 30 Jun 2017
    shares
    -$943KFull value: -$943,000 · USD · 30 Jun 2017 · Estimated from share changes and filing prices
    estimated

    Weight -0.99 percentage points

  5. UNH Exited

    UNITEDHEALTH GROUP INC

    -5.47KFull value: -5,465 · shares · 30 Jun 2017
    shares
    -$896KFull value: -$896,000 · USD · 30 Jun 2017 · Estimated from share changes and filing prices
    estimated

    Weight -0.94 percentage points

Estimates use share changes and filing prices. They are not trade proceeds. Options and principal positions are excluded.

Compare with Q1 2017

Holdings

Sym Weight Trade Impact Company Class Share Change Activity Value change SEC-reported value SEC-reported price Shares Principal
Filing details and SEC source
13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
What this filing covers

Period

Q2 2017

Calendar quarter covered by the filing.

13F holdings

245

Parsed equity rows, excluding option-only view rows.

Reported value

$106,011,000

SEC Form 13F market value, not total AUM.

Accepted by SEC

25 Jul 2017

EDGAR acceptance date.

How to read this filing
  • Start with the largest positions and changes, then open issuer-level rows for CUSIP-specific history.
  • Form 13F market value excludes cash and many non-13F assets, so it should not be treated as total assets under management.
  • SEC classifies this as a holdings report: this manager reports its visible U.S.-listed equity holdings in this filing.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Xiongwei Ju - Managing Partner
Manager location
Wanchai, Hong Kong
Source evidence Original filing metadata and source links for verification. 5 source fields
Accepted by SEC
25 Jul 2017, 11:52:05 UTC
SEC form
13F-HR
Prior SEC filing
Q1 2017 - 13 Apr 2017
Next SEC filing
Q3 2017 - 27 Oct 2017
Source filing
View source filing
This view compares filing 2017 Q2 with 2017 Q1. Changes are calculated against the previous SEC filing.
SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
* marks a reported price that did not pass the local price check.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Xiongwei Ju Managing Partner Central, Hong Kong 21 Jul 2017

Other Included Managers (1):

Num Name Location File Number
1 Parametrica Asset Management Ltd Wanchai 028-14605
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .